Our analysis provides evidence that a combination of multi-omics features such as IL-8, PF-4, MLH-1, and specific plasma PS and PE lipids can help predict tumour progression in the early stages of CRC. The gene discussed is CXCL8; the disease is colorectal carcinoma.